Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
2015 · Gastroenterology · 193 citations
https://doi.org/10.1053/j.gastro.2015.06.002
D
Dirk J. de Jong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
214
Papers
7.9K
Citations
49
h-index
106
i10-index
Dirk J. de Jong is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Acute Lymphoblastic Leukemia research. The author has an h-index of 49, co-authored 182 publications.
Papers by this author
worksEvolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up
2016 · PLoS ONE · 105 citations
https://doi.org/10.1371/journal.pone.0142481
Long-Term Clinical Outcomes After Switching from Remicade® to Biosimilar CT-P13 in Inflammatory Bowel Disease
2017 · Digestive Diseases and Sciences · 68 citations
https://doi.org/10.1007/s10620-017-4661-4
Genetic deficiency of NOD2 confers resistance to invasive aspergillosis
2018 · Nature Communications · 56 citations
https://doi.org/10.1038/s41467-018-04912-3
Effect of childbirth on the course of Crohn's disease; results from a retrospective cohort study in the Netherlands
2011 · BMC Gastroenterology · 38 citations
https://doi.org/10.1186/1471-230x-11-6
Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2
2016 · PLoS ONE · 34 citations
https://doi.org/10.1371/journal.pone.0159609
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat